Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 3/2014

01-06-2014 | Letter

Procalcitonin-guided therapy in severe sepsis and septic shock

Authors: Wan-Jie Gu, Jing-Chen Liu

Published in: Critical Care | Issue 3/2014

Login to get access

Excerpt

We read with interest the recent systematic review of procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock [1]. We congratulate and applaud their important work, but several important issues should be noted. …
Literature
1.
Prkno A, Wacker C, Brunkhorst FM, Schlattmann P: Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock - a systematic review and meta-analysis. Crit Care 2013, 17: R291. 10.1186/cc13157PubMedPubMedCentralCrossRef
2.
Deliberato RO, Marra AR, Sanches PR, Martino MD, Ferreira CE, Pasternak J, Paes AT, Pinto LM, dos Santos OF, Edmond MB: Clinical and economic impact of procalcitonin to shorten antimicrobial therapy in septic patients with proven bacterial infection in an intensive care setting. Diagn Microbiol Infect Dis 2013, 76: 266-271. 10.1016/j.diagmicrobio.2013.03.027PubMedCrossRef
3.
Blanco J, Muriel-Bombín A, Sagredo V, Taboada F, Gandía F, Tamayo L, Collado J, García-Labattut A, Carriedo D, Valledor M, De Frutos M, López MJ, Caballero A, Guerra J, Alvarez B, Mayo A, Villar J, Grupo de Estudios y Análisis en Cuidados Intensivos: Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit Care 2008, 12: R158. 10.1186/cc7157PubMedPubMedCentralCrossRef
Metadata
Title
Procalcitonin-guided therapy in severe sepsis and septic shock
Authors
Wan-Jie Gu
Jing-Chen Liu
Publication date
01-06-2014
Publisher
BioMed Central
Published in
Critical Care / Issue 3/2014
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc13856

Other articles of this Issue 3/2014

Critical Care 3/2014 Go to the issue

Commentary

Hypovitaminosis D and morbidity in critical illness: is there proof beyond reasonable doubt?

Commentary

Revisiting therapeutic hypothermia for severe traumatic brain injury… again

Research

Clinical assessment of peripheral perfusion to predict postoperative complications after major abdominal surgery early: a prospective observational study in adults

Research

The role of CXCL10 in the pathogenesis of experimental septic shock

Review

Extracorporeal carbon dioxide removal for patients with acute respiratory failure secondary to the acute respiratory distress syndrome: a systematic review

Review

Management of anticoagulant-related intracranial hemorrhage: an evidence-based review